CVR Energy, Inc. (CVI)
Price:
27.28 USD
( + 0.44 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Valero Energy Corporation
VALUE SCORE:
5
2nd position
Phillips 66
VALUE SCORE:
8
The best
Star Group, L.P.
VALUE SCORE:
13
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
CVR Energy, Inc., together with its subsidiaries, engages in the petroleum refining and nitrogen fertilizer manufacturing activities in the United States. It operates in two segments, Petroleum and Nitrogen Fertilizer. The Petroleum segment refines and markets gasoline, diesel fuel, and other refined products. It also owns and operates a coking medium-sour crude oil refinery in southeast Kansas; and a crude oil refinery in Wynnewood, Oklahoma, as well as supporting logistics assets. This segment primarily serves retailers, railroads, farm co-operatives, and other refiners/marketers. The Nitrogen Fertilizer segment owns and operates a nitrogen fertilizer plant in North America that utilizes a pet coke gasification process to produce nitrogen fertilizer products; and a nitrogen fertilizer facility in East Dubuque, Illinois that produces nitrogen fertilizers in the form of ammonia and urea ammonium nitrate (UAN). It primarily markets UAN products to agricultural customers; and ammonia products to agricultural and industrial customers. The company was founded in 1906 and is headquartered in Sugar Land, Texas. CVR Energy, Inc. is a subsidiary of Icahn Enterprises L.P.
NEWS

CVR Energy Q2 Revenue Beats by 4%
fool.com
2025-08-04 14:23:08CVR Energy Q2 Revenue Beats by 4%

enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trump's Recent CVI Diagnosis May Impact the Company
accessnewswire.com
2025-08-04 09:05:00- enVVeno is developing the VenoValve as a potential treatment option for the approximately 2.5 million patients in the U.S. suffering from severe deep Chronic Venous Insufficiency - FDA decision expected in 2H'2025 - Access the "What This Means" segment here IRVINE, CA / ACCESS Newswire / August 4, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno Medical" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that it participated in a Virtual Investor "What This Means" segment entitled, "enVVeno Medical - Making Veins Work Again - How President Trump's CVI Diagnosis is Raising Awareness." Rob Berman, CEO and Dr. Marc Glickman, CMO of enVVeno Medical discussed the progressive nature of chronic veinous insufficiency and whether President Trump may one day be a candidate for the VenoValve® following U.S. Food and Drug Administration (FDA) approval.

CVR Energy: Attractive Despite A Mixed Q2
seekingalpha.com
2025-08-02 23:33:33CVR Energy faced weak refining margins and high turnaround costs, but improving crack spreads and cost efficiencies offer cautious optimism for a rebound. Turnaround-related headwinds are largely behind, setting up Q3 for margin improvement, though execution remains a 'show-me story.' I expect dividend resumption in 2026, likely at a lower base, with special dividends possible during strong cycles; balance sheet progress is encouraging.

CVR Energy, Inc. (CVI) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-07-31 17:25:47CVR Energy, Inc. (NYSE:CVI ) Q2 2025 Earnings Conference Call July 31, 2025 1:00 PM ET Company Participants Dane J. Neumann - Executive VP, CFO, Treasurer & Assistant Secretary David L.

CVR Energy (CVI) Reports Q2 Loss, Misses Revenue Estimates
zacks.com
2025-07-30 19:26:08CVR Energy (CVI) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.09 per share a year ago.

CVR Energy names Mark Pytosh as CEO, adds Brett Icahn to board
reuters.com
2025-07-30 17:32:53Carl Icahn-backed CVR Energy on Wednesday named Mark Pytosh as chief executive officer and appointed Brett Icahn to its board.

CVR Energy Reports Second Quarter 2025 Results, Announces Leadership Transition Plans
globenewswire.com
2025-07-30 16:53:00SUGAR LAND, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- CVR Energy, Inc. (NYSE: CVI, “CVR Energy” or the “Company”) today announced second quarter 2025 net loss attributable to CVR Energy stockholders of $114 million, or $1.14 per diluted share, compared to second quarter 2024 net income attributable to CVR Energy stockholders of $21 million, or 21 cents per diluted share. Adjusted loss for the second quarter of 2025 was 23 cents per diluted share, compared to adjusted earnings per diluted share of 9 cents in the second quarter of 2024. Net loss for the second quarter of 2025 was $90 million, compared to net income of $38 million in the second quarter of 2024. Second quarter 2025 EBITDA loss was $24 million, compared to second quarter 2024 EBITDA of $103 million. Adjusted EBITDA for the second quarter of 2025 was $99 million, compared to adjusted EBITDA of $87 million in the second quarter of 2024.

Can These 5 Energy Stocks Beat Q2 Earnings Estimates?
zacks.com
2025-07-29 11:20:17Here's a preview of what to expect from energy stocks CRK, CVI, PUMP, AM and AR ahead of their quarterly earnings reports, set to be released tomorrow.

Earnings Preview: CVR Energy (CVI) Q2 Earnings Expected to Decline
zacks.com
2025-07-23 11:08:41CVR (CVI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

According to THE SAGE GROUP, The Current United States Prevalence of Chronic Venous Disease (CVD) Exceeds 190 Million. The Most Severe Stage, Chronic Venous Insufficiency (CVI), Afflicts Over 50 Million.
businesswire.com
2025-07-18 11:35:00BEAUFORT, S.C.--(BUSINESS WIRE)-- #CVD--A new report published by THE SAGE GROUP quantifies CVD prevalence and incidence for the 2020-2040 period. “Chronic venous disease afflicts 1.5 times as many people as all cardiovascular diseases combined, and five times more than those with diabetes. It is one of the most prevalent chronic diseases. However, CVD is significantly underestimated, underdiagnosed and undertreated,” stated Mary L. Yost, President. CVD represents a spectrum of medical conditions invo.

CVR Energy to Release Second Quarter 2025 Earnings Results
globenewswire.com
2025-07-17 08:30:00SUGAR LAND, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- CVR Energy, Inc. (NYSE: CVI) plans to release its second quarter 2025 earnings results on Wednesday, July 30, after the close of trading on the New York Stock Exchange. The Company also will host a teleconference call on Thursday, July 31, at 1 p.m. Eastern to discuss these results.

If You Invested in These 5 Dividend Stocks, You Could Make $4,300 per Year
247wallst.com
2025-06-25 15:32:59With the 10-year U.S. Treasury bond currently yielding 4.38%, interest rates are still abnormally high given positive job growth, trillions of dollars in U.S.

5 Broker-Favored Stocks to Watch Amid Cooling Inflation
zacks.com
2025-06-13 12:21:07With inflation easing and consumer confidence rebounding, brokers favor stocks like BTSG, ALGT, CVI, ALTG and CBRL.

CVR Energy: Recovery Can Continue
seekingalpha.com
2025-05-31 10:45:00Crack spreads have rebounded, supporting CVR Energy's margins and cash flow, especially with low gasoline inventories and favorable OPEC+ production dynamics. The costly Coffeyville refinery turnaround is nearly complete, with no major maintenance expected until 2027, positioning CVR for stronger H2 results. CVR's improved cash flow outlook should enable debt reduction and a likely dividend resumption in early 2026, with its UAN stake providing additional value.

Carl Icahn Buys More Shares, and Tesla Insider Bucks the Selling Trend
247wallst.com
2025-05-01 08:45:02Insider buying has slowed considerably in the past week or so, due largely to the current first-quarter earnings reporting season.

CVR Energy, Inc. (CVI) Q1 2025 Earnings Call Transcript
seekingalpha.com
2025-04-29 14:37:03CVR Energy, Inc. (NYSE:CVI ) Q1 2025 Results Conference Call April 29, 2025 1:00 PM ET Company Participants Richard Roberts - Financial Planning & Analysis & Investor Relations Dave Lamp - Chief Executive Officer Dane Neumann - Chief Financial Officer Conference Call Participants Manav Gupta - UBS Matthew Blair - Tudor Pickering Neil Mehta - Goldman Sachs John Royall - JPMorgan Paul Cheng - Scotiabank Operator Greetings, and welcome to the CVR Energy First Quarter 2025 Conference Call. At this time, all participants are in a listen-only mode.

CVR Energy Q2 Revenue Beats by 4%
fool.com
2025-08-04 14:23:08CVR Energy Q2 Revenue Beats by 4%

enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trump's Recent CVI Diagnosis May Impact the Company
accessnewswire.com
2025-08-04 09:05:00- enVVeno is developing the VenoValve as a potential treatment option for the approximately 2.5 million patients in the U.S. suffering from severe deep Chronic Venous Insufficiency - FDA decision expected in 2H'2025 - Access the "What This Means" segment here IRVINE, CA / ACCESS Newswire / August 4, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno Medical" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that it participated in a Virtual Investor "What This Means" segment entitled, "enVVeno Medical - Making Veins Work Again - How President Trump's CVI Diagnosis is Raising Awareness." Rob Berman, CEO and Dr. Marc Glickman, CMO of enVVeno Medical discussed the progressive nature of chronic veinous insufficiency and whether President Trump may one day be a candidate for the VenoValve® following U.S. Food and Drug Administration (FDA) approval.

CVR Energy: Attractive Despite A Mixed Q2
seekingalpha.com
2025-08-02 23:33:33CVR Energy faced weak refining margins and high turnaround costs, but improving crack spreads and cost efficiencies offer cautious optimism for a rebound. Turnaround-related headwinds are largely behind, setting up Q3 for margin improvement, though execution remains a 'show-me story.' I expect dividend resumption in 2026, likely at a lower base, with special dividends possible during strong cycles; balance sheet progress is encouraging.

CVR Energy, Inc. (CVI) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-07-31 17:25:47CVR Energy, Inc. (NYSE:CVI ) Q2 2025 Earnings Conference Call July 31, 2025 1:00 PM ET Company Participants Dane J. Neumann - Executive VP, CFO, Treasurer & Assistant Secretary David L.

CVR Energy (CVI) Reports Q2 Loss, Misses Revenue Estimates
zacks.com
2025-07-30 19:26:08CVR Energy (CVI) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.09 per share a year ago.

CVR Energy names Mark Pytosh as CEO, adds Brett Icahn to board
reuters.com
2025-07-30 17:32:53Carl Icahn-backed CVR Energy on Wednesday named Mark Pytosh as chief executive officer and appointed Brett Icahn to its board.

CVR Energy Reports Second Quarter 2025 Results, Announces Leadership Transition Plans
globenewswire.com
2025-07-30 16:53:00SUGAR LAND, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- CVR Energy, Inc. (NYSE: CVI, “CVR Energy” or the “Company”) today announced second quarter 2025 net loss attributable to CVR Energy stockholders of $114 million, or $1.14 per diluted share, compared to second quarter 2024 net income attributable to CVR Energy stockholders of $21 million, or 21 cents per diluted share. Adjusted loss for the second quarter of 2025 was 23 cents per diluted share, compared to adjusted earnings per diluted share of 9 cents in the second quarter of 2024. Net loss for the second quarter of 2025 was $90 million, compared to net income of $38 million in the second quarter of 2024. Second quarter 2025 EBITDA loss was $24 million, compared to second quarter 2024 EBITDA of $103 million. Adjusted EBITDA for the second quarter of 2025 was $99 million, compared to adjusted EBITDA of $87 million in the second quarter of 2024.

Can These 5 Energy Stocks Beat Q2 Earnings Estimates?
zacks.com
2025-07-29 11:20:17Here's a preview of what to expect from energy stocks CRK, CVI, PUMP, AM and AR ahead of their quarterly earnings reports, set to be released tomorrow.

Earnings Preview: CVR Energy (CVI) Q2 Earnings Expected to Decline
zacks.com
2025-07-23 11:08:41CVR (CVI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

According to THE SAGE GROUP, The Current United States Prevalence of Chronic Venous Disease (CVD) Exceeds 190 Million. The Most Severe Stage, Chronic Venous Insufficiency (CVI), Afflicts Over 50 Million.
businesswire.com
2025-07-18 11:35:00BEAUFORT, S.C.--(BUSINESS WIRE)-- #CVD--A new report published by THE SAGE GROUP quantifies CVD prevalence and incidence for the 2020-2040 period. “Chronic venous disease afflicts 1.5 times as many people as all cardiovascular diseases combined, and five times more than those with diabetes. It is one of the most prevalent chronic diseases. However, CVD is significantly underestimated, underdiagnosed and undertreated,” stated Mary L. Yost, President. CVD represents a spectrum of medical conditions invo.

CVR Energy to Release Second Quarter 2025 Earnings Results
globenewswire.com
2025-07-17 08:30:00SUGAR LAND, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- CVR Energy, Inc. (NYSE: CVI) plans to release its second quarter 2025 earnings results on Wednesday, July 30, after the close of trading on the New York Stock Exchange. The Company also will host a teleconference call on Thursday, July 31, at 1 p.m. Eastern to discuss these results.

If You Invested in These 5 Dividend Stocks, You Could Make $4,300 per Year
247wallst.com
2025-06-25 15:32:59With the 10-year U.S. Treasury bond currently yielding 4.38%, interest rates are still abnormally high given positive job growth, trillions of dollars in U.S.

5 Broker-Favored Stocks to Watch Amid Cooling Inflation
zacks.com
2025-06-13 12:21:07With inflation easing and consumer confidence rebounding, brokers favor stocks like BTSG, ALGT, CVI, ALTG and CBRL.

CVR Energy: Recovery Can Continue
seekingalpha.com
2025-05-31 10:45:00Crack spreads have rebounded, supporting CVR Energy's margins and cash flow, especially with low gasoline inventories and favorable OPEC+ production dynamics. The costly Coffeyville refinery turnaround is nearly complete, with no major maintenance expected until 2027, positioning CVR for stronger H2 results. CVR's improved cash flow outlook should enable debt reduction and a likely dividend resumption in early 2026, with its UAN stake providing additional value.

Carl Icahn Buys More Shares, and Tesla Insider Bucks the Selling Trend
247wallst.com
2025-05-01 08:45:02Insider buying has slowed considerably in the past week or so, due largely to the current first-quarter earnings reporting season.

CVR Energy, Inc. (CVI) Q1 2025 Earnings Call Transcript
seekingalpha.com
2025-04-29 14:37:03CVR Energy, Inc. (NYSE:CVI ) Q1 2025 Results Conference Call April 29, 2025 1:00 PM ET Company Participants Richard Roberts - Financial Planning & Analysis & Investor Relations Dave Lamp - Chief Executive Officer Dane Neumann - Chief Financial Officer Conference Call Participants Manav Gupta - UBS Matthew Blair - Tudor Pickering Neil Mehta - Goldman Sachs John Royall - JPMorgan Paul Cheng - Scotiabank Operator Greetings, and welcome to the CVR Energy First Quarter 2025 Conference Call. At this time, all participants are in a listen-only mode.